Urick, senior principal health outcomes researcher, shares more about his Spotlight Session at the Academy of Managed Care Pharmacy (AMCP)’s Annual Meeting

Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024

Prime Therapeutics researchers share how the model helps to optimize drug therapy and lower costs

Prime Careers Spotlight: November 2024 Check out our latest job openings. Together, we can help make health care better by helping clients and members navigate pharmacy benefits. Investment...

Welcome to Mid-Market Central At Prime Therapeutics (Prime), we value our mid-market partner relationships and continually strive to create exceptional experiences for our customers. This resource...

A look at the specialty landscape and how Prime delivers value to employers

Diversity, equity and inclusion Our commitment to diversity, equity and inclusion (DEI) is rooted in our purpose and dedication to serving others. Breadcrumb Home Who we are Diversity, equity and...

publications Pancreatic cancer: Innovative therapy approved, but unmet need continues April 14, 2025 Author: Simone Ndujiuba, PharmD, BCOP In the United States, pancreatic cancer is the fourth...

Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this...

Eyebrow High-Cost Therapy Profile: February Detailed information about Marnetegragene autotemcel Intravenous (IV) High Cost Therapy Profile Gene Therapy/Immunology Marnetegragene autotemcel...

Breadcrumb Home Client Communication Pharmaceutical tariffs: Updates and featured news Pharmaceutical tariffs: Updates & news Your source for updates and featured client news on the evolving U.S....

Managed Markets Insight & Technology (MMIT)

Ben Urick, senior director of health outcomes, and Landon Marshall, health outcomes research principal, share more about their educational session and research poster on GLP-1s

Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting.

Read Clinical News: August 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics FDA SAFETY ALERT ON COMPOUNDED...

publications GLP-1 Pipeline Update: November 2024 Quarterly view of the GLP-1 pipeline and anticipated indications November 21, 2024 Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Vice...

Publications Clinical Highlights: March 2025 Your monthly source for drug information highlights. March 27, 2025 Trending topics As of late February 2025, the United States (U.S.) Centers for...

publications Quarterly Drug Pipeline: October 2024 Clinical insights and competitive intelligence on anticipated drugs in development October 31, 2025 Editor-in-chief's message Welcome to the Prime...

Quarterly Drug Pipeline: July 2024 Clinical insights and competitive intelligence on anticipated drugs in development Editor-in-chief's message Welcome to the Prime Quarterly Drug Pipeline! Dive...

Quarterly Drug Pipeline: April 2024 Clinical insights and competitive intelligence on anticipated drugs in development Drug Pipeline Clinical insights and competitive intelligence on anticipated...